AIM: To examine the interactions between cytotoxin-associated gene (CagA) positive Helicobacter pylori infection and smoking in non-cardiac gastric cancer. METHODS: A case-control study (257 cases and 514 frequency-matched controls) was conducted from September 2008 to July 2010 in Xi'an, China. Cases were newly diagnosed, histologically confirmed non-cardiac cancer. Controls were randomly selected from similar communities to the cases and were further matched by sex and age (± 5 years). A face-to-face interview was performed by the investigators for each participant. Data were obtained using a standardized questionnaire that included questions regarding known or suspected lifestyle and environmental risk factors of gastric cancer. A 5 mL sample of fasting venous blood was taken. CagA infection was serologically detected by enzyme-linked immunosorbent assays. RESULTS: Smoking and CagA infection were statistically significant risk factors of non-cardiac cancer. CagA was categorized in tertiles, and the odds ratio (OR) was 12.4 (95% CI: 6.1-20.3, P = 0.003) for CagA after being adjusted for confounding factors when the high-exposure category was compared with the low-exposure category. Smokers had an OR of 5.4 compared with subjects who never smoked (95% CI: 2.3-9.0, P = 0.002). The OR of non-cardiac cancer was 3.5 (95% CI: 1.8-5.3) for non-smokers with CagA infection, 3.5 (95% CI: 1.9-5.1) for smokers without CagA infection, and 8.7 (95% CI: 5.1-11.9) for smokers with CagA infection compared with subjects without these risk factors. After adjusting for confounding factors, the corresponding ORs of non-cardiac cancer were 3.2 (95% CI: 1.5-6.8), 2.7 (95% CI: 1.3-4.9) and 19.5 (95% CI: 10.3-42.2), respectively. There was a multiplicative interaction between smoking and CagA, with a synergistic factor of 2.257 (Z = 2.315, P = 0.021). CONCLUSION: These findings support a meaningful interaction between CagA and smoking for the risk of gastric cancer which may have implications for its early detection.
AIM: To examine the interactions between cytotoxin-associated gene (CagA) positive Helicobacter pyloriinfection and smoking in non-cardiac gastric cancer. METHODS: A case-control study (257 cases and 514 frequency-matched controls) was conducted from September 2008 to July 2010 in Xi'an, China. Cases were newly diagnosed, histologically confirmed non-cardiac cancer. Controls were randomly selected from similar communities to the cases and were further matched by sex and age (± 5 years). A face-to-face interview was performed by the investigators for each participant. Data were obtained using a standardized questionnaire that included questions regarding known or suspected lifestyle and environmental risk factors of gastric cancer. A 5 mL sample of fasting venous blood was taken. CagAinfection was serologically detected by enzyme-linked immunosorbent assays. RESULTS: Smoking and CagAinfection were statistically significant risk factors of non-cardiac cancer. CagA was categorized in tertiles, and the odds ratio (OR) was 12.4 (95% CI: 6.1-20.3, P = 0.003) for CagA after being adjusted for confounding factors when the high-exposure category was compared with the low-exposure category. Smokers had an OR of 5.4 compared with subjects who never smoked (95% CI: 2.3-9.0, P = 0.002). The OR of non-cardiac cancer was 3.5 (95% CI: 1.8-5.3) for non-smokers with CagAinfection, 3.5 (95% CI: 1.9-5.1) for smokers without CagAinfection, and 8.7 (95% CI: 5.1-11.9) for smokers with CagAinfection compared with subjects without these risk factors. After adjusting for confounding factors, the corresponding ORs of non-cardiac cancer were 3.2 (95% CI: 1.5-6.8), 2.7 (95% CI: 1.3-4.9) and 19.5 (95% CI: 10.3-42.2), respectively. There was a multiplicative interaction between smoking and CagA, with a synergistic factor of 2.257 (Z = 2.315, P = 0.021). CONCLUSION: These findings support a meaningful interaction between CagA and smoking for the risk of gastric cancer which may have implications for its early detection.
Authors: N Muñoz; I Kato; S Peraza; G Lopez; E Carrillo; H Ramirez; J Vivas; D Castro; V Sanchez; O Andrade; E Buiatti; W Oliver Journal: Cancer Epidemiol Biomarkers Prev Date: 1996-01 Impact factor: 4.254
Authors: Meira Epplein; Abraham M Y Nomura; Jean H Hankin; Martin J Blaser; Guillermo Perez-Perez; Grant N Stemmermann; Lynne R Wilkens; Laurence N Kolonel Journal: Cancer Causes Control Date: 2008-03-28 Impact factor: 2.506
Authors: Julia Butt; Matthew G Varga; Tianyi Wang; Shoichiro Tsugane; Taichi Shimazu; Wei Zheng; Christian C Abnet; Keun-Young Yoo; Sue K Park; Jeongseon Kim; Sun Ha Jee; You-Lin Qiao; Xiao-Ou Shu; Tim Waterboer; Michael Pawlita; Meira Epplein Journal: Cancer Prev Res (Phila) Date: 2019-07-26
Authors: Miguel Santibáñez; Estefanía Aguirre; Sofía Belda; Nuria Aragones; Jesús Saez; Juan Carlos Rodríguez; Antonio Galiana; Javier Sola-Vera; Montserrat Ruiz-García; María Paz-Zulueta; Raquel Sarabia-Lavín; Alicia Brotons; Elena López-Girona; Estefanía Pérez; Carlos Sillero; Gloria Royo Journal: PLoS One Date: 2015-03-20 Impact factor: 3.240